United States · Venture startup
8 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$118Mraised across 8 rounds since 2010, from 8 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $12M sold, first sale Mar 2015
Reported by finsmes.comSEC filing: $32M sold, first sale Oct 2013
Reported by fiercebiotech.comSEC filing: $8.7M sold, first sale Jan 2013
Reported by catabasispharma.com
Reported by fiercebiotech.comSEC filing: $7.7M sold, first sale Apr 2010
No investor was named in the report.
Reported by sec.govSEC filing: $2.1M sold, first sale Dec 2008
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Advanced Technology VenturesSV Life Sciences
Clarus VenturesMedImmune Ventures
Lightstone VenturesMissing a round, or an investor who was in one? Tell us.
Catabasis Pharmaceuticals's investors include Advanced Technology Ventures, SV Life Sciences, Clarus Ventures, MedImmune Ventures and Lightstone Ventures.
Catabasis Pharmaceuticals has raised $118M across 8 rounds since 2010.
Catabasis Pharmaceuticals's most recent round was a Venture of $12M in Mar 2015.
Catabasis Pharmaceuticals's largest round on record is $39M (Series A), in Apr 2010.
Catabasis Pharmaceuticals's first round on record, in Apr 2010, was backed by Advanced Technology Ventures, SV Life Sciences and Clarus Ventures and 1 others.
Catabasis Pharmaceuticals's latest named round is a Venture, in Mar 2015.
Catabasis Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·